Autobio Diagnostics Co. Ltd. A | Ownership
Companies that own Autobio Diagnostics Co. Ltd. A
China Universal Asset Management Co., Ltd.
7,488,517
5.49%
5,528,405
0.63%
09/30/2017
ABC-CA Fund Management Co., Ltd.
1,807,251
1.32%
1,807,251
1.12%
09/30/2017
Zhonghai Fund Management Co., Ltd.
1,736,005
1.27%
1,716,005
2.15%
12/31/2017
UBS SDIC Fund Management Co., Ltd.
1,581,231
1.15%
1,148,831
1.19%
09/30/2017
China Merchants Fund Management Co., Ltd.
850,511
0.62%
34,000
0.21%
12/31/2017
New China Fund Management Co., Ltd.
735,308
0.54%
605,402
0.44%
12/31/2017
Bosera Asset Management Co., Ltd.
717,125
0.53%
717,125
0.06%
12/31/2017
ICBC Credit Suisse Asset Management Co., Ltd.
422,856
0.31%
-679,130
0.06%
12/31/2017
China Southern Asset Management Co., Ltd.
377,023
0.28%
190,535
0.03%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
345,037
0.25%
341,337
0.39%
12/31/2017
| Address |
No. 87 Bieyi Road
Zhengzhou Henan 450016
China
|
|
Employees
|
- |
| Website |
http://www.autobio.com.cn |
| Updated |
07/08/2019 |
| Autobio Diagnostics Co., Ltd. engages in the research and development, manufacture, and distribution of clinical diagnostic products. It focuses on immunoassays, clinical microbiology, and instrumentation. The company's products include clinical laboratory improvement amendments, enzyme-linked immunosorbent assay, point-of-care testing, mycoplasma identification enumeration susceptibility, blood culture bottle, cacterial vaginosis, rapid test strips and devices, microplate luminometer, elisa reader, and microplate washer. |
